Article

DNA diagnostics startup MedGenome raised $30 million (nearly INR 192 crore) in Series C funding round led by Sequoia India and Sofina …

You have read of your 8 free articles this month.

Subscribe to
Medgenera All-Access

Enjoy unlimited access to all contents, resources, exclusive market research reports, databases, surveys and many more features by subscribing to Medgenera All-Access.

Access articles & resources worth up to US $4, 000 per month.

Authentic, Ad-free Reporting
High-quality, Exclusive Content
Original Market Research Reports
Original Resources & Databases
Global Surveys & Guidelines
Lowest Subscription Pricing

Healthcare News You Won't Read Elsewhere

Most up-to-date information, original and in-depth reviews, full-length exclusive market reports and forecasts, full-access to the smart knowledge base centres, useful resources and databases.

Access articles & resources worth up to $4000.

More in Funding


Funding

Locus Raises $19 Million, Pushes First CRISPR-CAS3 Based Antimicrobial into Clinic

Infectious disease startup, Locus Biosciences received $19 million in Series A funding round, led by Artis Ventures. The rising concern ...

Funding

4 Ebola Vaccines and Drugs the US Stores in Kitty to Combat Epidemic

Three years ago, the world was fighting with the deadly virus of Ebola without the armor of any highly efficient ...

Funding

Genetic Diagnostics Startup MedGenome Raised $30 Million in Series C Funding

DNA diagnostics startup MedGenome raised $30 million (nearly INR 192 crore) in Series C funding round led by Sequoia India and Sofina ...

Funding

Indian Startup ‘Bugworks Research’ Receives Funding to Tackle Deadliest ‘Superbugs’

Antibiotics are a crucial part of healthcare but their overuse or misuse has led to the generation of deadly antibiotic ...

Most Popular


GROW

7 New Ideas to Start a Healthcare Business in India (2018)

Seven new #healthcare #business ideas in India in 2018. Which one would you prefer to pursue?

NEWLY PUBLISHED

Pharma Patents: Can India Reward Incremental Innovation?

Chandramouli Natarajan is an Associate Scientist, Ricon pharma LLC, Denville, USA. He has presented his opinion and views on the Pharmaceutical patents issues in India. This article is available for free to read and share.

Leave a reply